104 related articles for article (PubMed ID: 19909766)
21. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism.
Lin J; Schyschka L; Mühl-Benninghaus R; Neumann J; Hao L; Nussler N; Dooley S; Liu L; Stöckle U; Nussler AK; Ehnert S
Arch Toxicol; 2012 Jan; 86(1):87-95. PubMed ID: 21735230
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying the inhibition of the cytochrome P450 system by copper ions.
Letelier ME; Faúndez M; Jara-Sandoval J; Molina-Berríos A; Cortés-Troncoso J; Aracena-Parks P; Marín-Catalán R
J Appl Toxicol; 2009 Nov; 29(8):695-702. PubMed ID: 19629952
[TBL] [Abstract][Full Text] [Related]
24. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
Neve EP; Ingelman-Sundberg M
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
[TBL] [Abstract][Full Text] [Related]
25. Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor.
Darnell M; Schreiter T; Zeilinger K; Urbaniak T; Söderdahl T; Rossberg I; Dillnér B; Berg AL; Gerlach JC; Andersson TB
Drug Metab Dispos; 2011 Jul; 39(7):1131-8. PubMed ID: 21436404
[TBL] [Abstract][Full Text] [Related]
26. HepaRG cells as human-relevant in vitro model to study the effects of inflammatory stimuli on cytochrome P450 isoenzymes.
Rubin K; Janefeldt A; Andersson L; Berke Z; Grime K; Andersson TB
Drug Metab Dispos; 2015 Jan; 43(1):119-25. PubMed ID: 25371393
[TBL] [Abstract][Full Text] [Related]
27. Modulatory actions of o-coumaric acid on carcinogen-activating cytochrome P450 isozymes and the potential for drug interactions in human hepatocarcinoma cells.
Sen A; Terzioglu G; Atmaca P; Celik G; Ozgun O; Arslan S
Pharm Biol; 2015; 53(9):1391-8. PubMed ID: 25880144
[TBL] [Abstract][Full Text] [Related]
28. A murine scavenger receptor MARCO recognizes polystyrene nanoparticles.
Kanno S; Furuyama A; Hirano S
Toxicol Sci; 2007 Jun; 97(2):398-406. PubMed ID: 17361018
[TBL] [Abstract][Full Text] [Related]
29. Genistein Affects Expression of Cytochrome P450 (CYP450) Genes in Hepatocellular Carcinoma (HEPG2/C3A) Cell Line.
Lepri SR; Sartori D; Semprebon SC; Baranoski A; Coatti GC; Mantovani MS
Drug Metab Lett; 2018; 12(2):138-144. PubMed ID: 29984664
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing.
Fröhlich E; Meindl C; Roblegg E; Griesbacher A; Pieber TR
Nanotoxicology; 2012 Jun; 6(4):424-39. PubMed ID: 21627401
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa.
Roblegg E; Fröhlich E; Meindl C; Teubl B; Zaversky M; Zimmer A
Nanotoxicology; 2012 Jun; 6(4):399-413. PubMed ID: 21591874
[TBL] [Abstract][Full Text] [Related]
32. Metabolic characteristics and enflurane defluorination of cytochrome P450-dependent monooxygenases in human hepatocellular carcinoma.
Chen TL; Hou WY; Sun WZ; Wu GJ; Wang KC; Peng WL; Lin CJ
Acta Anaesthesiol Sin; 1997 Mar; 35(1):7-14. PubMed ID: 9212475
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric characterization by flow cytometry of flow-sorted subpopulations of a human hepatoma cell line useful for drug research.
O'Connor JE; Martínez A; Castell JV; Gómez-Lechón MJ
Cytometry A; 2005; 63(1):48-58. PubMed ID: 15593349
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 enzymes: ubiquitous "receptors" for drugs.
LaBella FS
Can J Physiol Pharmacol; 1991 Aug; 69(8):1129-32. PubMed ID: 1664291
[TBL] [Abstract][Full Text] [Related]
35. Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome.
Sekretarska J; Szczepaniak J; Sosnowska M; Grodzik M; Kutwin M; Wierzbicki M; Jaworski S; Bałaban J; Daniluk K; Sawosz E; Chwalibog A; Strojny B
Materials (Basel); 2019 Dec; 12(24):. PubMed ID: 31835701
[TBL] [Abstract][Full Text] [Related]
36. Application of the DataChip/MetaChip technology for the evaluation of ajoene toxicity in vitro.
Lee DW; Lee MY; Ku B; Yi SH; Ryu JH; Jeon R; Yang M
Arch Toxicol; 2014 Feb; 88(2):283-90. PubMed ID: 23892724
[TBL] [Abstract][Full Text] [Related]
37. [Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro].
Pawłowska M; Augustin E
Postepy Hig Med Dosw (Online); 2011 Jun; 65():367-76. PubMed ID: 21734321
[TBL] [Abstract][Full Text] [Related]
38. Identifying and localizing intracellular nanoparticles using Raman spectroscopy.
Dorney J; Bonnier F; Garcia A; Casey A; Chambers G; Byrne HJ
Analyst; 2012 Mar; 137(5):1111-9. PubMed ID: 22273712
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of cytochrome P450 isoenzymes in cultured human epidermal cells.
Van Pelt FN; Meierink YJ; Blaauboer BJ; Weterings PJ
J Histochem Cytochem; 1990 Dec; 38(12):1847-51. PubMed ID: 2254648
[TBL] [Abstract][Full Text] [Related]
40. In-vitro permeability of neutral polystyrene particles via buccal mucosa.
Teubl BJ; Meindl C; Eitzlmayr A; Zimmer A; Fröhlich E; Roblegg E
Small; 2013 Feb; 9(3):457-66. PubMed ID: 23112142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
